| Europeans With Rare Diseases Now Gaining Improved Access To Orphan Drugs |
Bad Gastein, 7 October |
| Entertainment Industry Panel Featured at Entertainment Industries Council and Shire Hosted “Picture This” Forum on ADHD |
Entertainment Industries Council, Inc., June 14, 2011 |
| Stockwatch: Orphans are better, if they work |
Scrip, May 31, 2011 |
| Shire receives additional Vyvanse patent challenges |
Scrip, May 26, 2011 |
| Banks lead FTSE 100 higher but Shire slips on competition concerns |
guardian.co.uk, 25 May, 2011 |
| Shire: Receives Vyvanse ANDA Notices From Amneal, Watson |
WSJ.com, May 25, 2011 |
| Shire hit over patent challenge to key drug |
FT.com, May 19, 2011 |
| Shire’s Purchase of Advanced BioHealing for $750 Million Hits ‘Sweet Spot’ |
bloomberg.com, May 18, 2011 |
| Shire moves into regenerative medicine with $750m deal |
telegraph.co.uk, May 18, 2011 |
| Shire buys Advanced BioHealing for $750m |
FT.com, May 18, 2011 |
| Shire slips after $750m US wound healing deal |
guardian.co.uk, May 18, 2011 |
| 2nd UPDATE: Shire To Buy Advanced BioHealing For $750 Million |
WSJ.com, May 18, 2011 |
| A Rare Win For Venture Investors In Regenerative Medicine |
WSJ.com, May 17, 2011 |
| UPDATE 2-Shire to buy Advanced BioHealing for $750 mln |
Reuters, May 17, 2011 |
| Is Pharma's big brand era over? |
Reuters, May 13, 2011 |
| Shire's 'Sore Thumb' Growth May Catch Eye of Drugmakers |
bloomberg.com, May 13, 2011 |
| Video: TWIB: Why Human Genetic Therapies stayed in Mass |
necn.com May 13, 2011 |
| Video: Shire CEO Russell on ADHD Drugs |
bloomberg.com, May 11, 2011 |
| Shire on hunt for assets in stem cells, genetics |
Reuters, May 11, 2011 |
| Shire shares fall despite strong rare disease drug sales |
telegraph.co.uk, Apr 28, 2011 |
